Back to Search Start Over

[The council for new therapies position on eculizumab is unacceptable]

Details

Database :
OpenAIRE
Journal :
Europe PubMed Central, ResearcherID
Accession number :
edsair.dedup.wf.001..caf1db7c3f49ab8c6d62807aeb5e899b